简体中文 | 繁體中文 | English

Press Releases

2025-10-10 15:52 Children's Hospital Los Angeles Recognized Among the United States' Top 10 Children's Hospitals for 17 Consecutive Years
2025-10-10 15:47 Bimiralisib, Topical PI3K/mTOR Inhibitor Shows Up To 92% Clearance Rate And Superior Tolerability In Proof-Of-Concept Actinic Keratosis Study
2025-10-10 15:41 Heidi Secures $65 Million USD in Series B Funding to Accelerate Building an AI Care Partner for Every Clinician
2025-10-10 15:36 TCG Crossover (“TCGX”) Announces Oversubscribed $1.3B TCGX Fund III
2025-10-10 15:30 INVESTMENT FORUM - Senegal Is Betting on Forum Invest in Senegal 2025 (Fii 2025) to Accelerate the Inflow of Foreign Capital
2025-10-10 15:26 G2 Risk Solutions Finalizes EverC Transaction
2025-10-10 15:18 Universe of Existence, Universe of Perception: teamLab Biovortex Kyoto Opening on October 7, 2025. Fully Unveiled
2025-10-10 12:10 Sharjah Ruler Opens Centre for Arabic Studies in Portugal
2025-10-10 12:01 World Green Economy Summit Hosts a High-Level Ministerial Roundtable
2025-10-10 11:53 Esmark Appoints Jack Biegalski CEO of Esmark Steel Group, Alvarez to Lead Esmark International
2025-10-10 11:47 With the Redevelopment Works Underway, UCC Holding on behalf of the JV Partners Signs Five Design and Consultancy Agreements with Global Firms for the Development of Damascus International Airport
2025-10-10 11:40 Zayed Sustainability Prize Announces 2026 Finalists Driving Global Impact
2025-10-10 11:29 MWX partners with SMESCO and Ministry of SMEs to provide Indonesian SMEs with ready to use AI solutions
2025-10-10 11:21 New Global GCCA Initiative to Rally Building Value Chain for Cement and Concrete Net Zero Mission
2025-10-10 11:15 Fanatics Collectibles and Kayou Join Forces to Bring NBA Trading Cards to China
2025-10-10 11:09 Carta Acquires Accelex to Deliver AI-Powered Data Automation and Transparency for Capital Allocators
2025-10-10 11:02 Marjan Announces New Mixed-Use Beach Town Destination, Marjan Beach
2025-10-10 10:59 Neuraptive Therapeutics, Inc. Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating the Safety and Efficacy of NTX-001 Compared to Standard of Care in the Treatment of Upper Extremity Transected Nerves Requiring Surgical Repair
2025-10-10 10:56 Andersen Consulting Strengthens Platform with NewVision Solutions
2025-10-10 10:50 WETEX 2025 Promotes the Competitiveness of Eco-Friendly Vehicles